Heart Health Hub 2026 — AI Cardiac Risk, BP & Early Warning

Cardiovascular disease causes 17.9 million deaths per year — the world's #1 killer (WHO 2024). Yet the majority are preventable when risk is detected early. JourneyForHealth combines validated risk scores (ASCVD, Framingham, QRISK3, INTERHEART), AI-driven early warning (HRV, vocal biomarkers, sleep architecture), and structured cardiac rehab to drop event risk by up to 40%.

What You Can Do Here

• Cardiac Risk Assessment — Free 2-minute ASCVD + Framingham + family history calculator with personalised plan.
• AI ECG Reader — Upload an ECG image. AI flags AFib, bradycardia, ST changes, MI patterns. Cardiologist-reviewed.
• Cardiac Early-Warning — Continuous HRV + voice + sleep AI predicting cardiac events 5+ years out.
• Cardiac Rehabilitation — 12-week structured rehab. Cuts re-hospitalisation 35%.
• Heart Failure Tracker — Daily weight, fluids, BP, symptoms. AI flags decompensation 7 days early.
• BP Lowering Programme — DASH + meds + tracking. ~11 mmHg drop at 8 weeks.
• Heart Wearable Comparison — Apple Watch vs Fitbit vs Garmin vs Withings, AFib accuracy compared.
• Cardiac Surgery Abroad — CABG $4.5K India vs $123K US, top JCI hospitals.

The Numbers That Matter

• Blood pressure: Below 120/80 ideal. Above 130/80 = stage 1 hypertension (ACC/AHA 2024). Each 10 mmHg systolic reduction lowers stroke risk by 27%, heart attack by 17%.
• LDL cholesterol: Below 100 mg/dL for primary prevention, below 70 mg/dL for secondary prevention. Each 38 mg/dL drop with statins lowers events by 22%.
• Resting heart rate: 60–80 bpm normal. RHR persistently above 80 doubles cardiovascular mortality (Copenhagen Heart Study).
• HbA1c: Below 7% for diabetics. Each 1% drop cuts microvascular events by 37%.
• VO2 max: Top 20% by age = 5x lower all-cause mortality vs bottom 20% (Mandsager 2018, JAMA).

Evidence-Based Cardiac Risk Reduction

1. Statins — 25–35% relative risk reduction for first heart attack. NNT ~50 for primary prevention, ~17 for secondary.
2. Antihypertensives — Each 5 mmHg systolic reduction → 10% MACE reduction (Lancet 2021 meta).
3. Cardiac rehab post-MI — 25% relative reduction in mortality at 5 years (Cochrane 2021).
4. Mediterranean diet — 30% reduction in major cardiovascular events (PREDIMED trial).
5. Exercise — 150 min/week moderate exercise lowers cardiac mortality 35%.
6. Smoking cessation — Halves cardiovascular event risk within 1 year, returns to non-smoker level by 5–15 years.
7. SGLT2 inhibitors (in HF or CKD) — 25–30% reduction in HF hospitalisation and CV death (DAPA-HF, EMPEROR-Reduced).

Frequently Asked Questions

What is the best heart-disease risk calculator?

For people aged 40–75 in the US, the 2018 ACC/AHA ASCVD calculator is standard. In the UK, QRISK3. For South Asians, the QRISK3 South-Asian-adjusted version captures elevated risk better than ASCVD. Globally, INTERHEART (PURE study-derived) works across ethnicities. JFORH combines all three for the most robust estimate.

Can wearables actually detect heart disease?

For atrial fibrillation, yes — Apple Watch, Fitbit, and Withings have FDA/CE clearance with 95–98% specificity. For heart attack prediction, current consumer wearables are NOT diagnostic but can flag concerning patterns (sustained tachycardia, drop in HRV, abnormal ECG morphology) that warrant clinical evaluation.

When should I see a cardiologist?

See a cardiologist if you have: chest pain on exertion, unexplained shortness of breath, palpitations with dizziness, family history of sudden cardiac death under 55, ASCVD 10-year risk >20%, or known CAD/HF/AFib. Otherwise, primary care with periodic screening is sufficient.

How is cardiac care abroad different?

For routine procedures (angioplasty, CABG, valve replacement, pacemaker), top JCI hospitals in India, Turkey, and Thailand match US/UK quality at 5–15% of the cost. For complex/rare cases (paediatric cardiac, advanced heart failure, transplant) Germany, US, and South Korea remain the global leaders. See cost comparison.